Cargando…
Minimal Change Disease Associated With Durvalumab
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484110/ https://www.ncbi.nlm.nih.gov/pubmed/34622115 http://dx.doi.org/10.1016/j.ekir.2021.08.021 |
_version_ | 1784577248027738112 |
---|---|
author | Toda, Masataro G. Fujii, Kentaro Kato, Ai Yoshifuji, Ayumi Komatsu, Motoaki Amino, Yoshiaki Kitazono, Satoru Hashiguchi, Akinori Ryuzaki, Munekazu |
author_facet | Toda, Masataro G. Fujii, Kentaro Kato, Ai Yoshifuji, Ayumi Komatsu, Motoaki Amino, Yoshiaki Kitazono, Satoru Hashiguchi, Akinori Ryuzaki, Munekazu |
author_sort | Toda, Masataro G. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8484110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84841102021-10-06 Minimal Change Disease Associated With Durvalumab Toda, Masataro G. Fujii, Kentaro Kato, Ai Yoshifuji, Ayumi Komatsu, Motoaki Amino, Yoshiaki Kitazono, Satoru Hashiguchi, Akinori Ryuzaki, Munekazu Kidney Int Rep Letter to the Editor Elsevier 2021-09-01 /pmc/articles/PMC8484110/ /pubmed/34622115 http://dx.doi.org/10.1016/j.ekir.2021.08.021 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Letter to the Editor Toda, Masataro G. Fujii, Kentaro Kato, Ai Yoshifuji, Ayumi Komatsu, Motoaki Amino, Yoshiaki Kitazono, Satoru Hashiguchi, Akinori Ryuzaki, Munekazu Minimal Change Disease Associated With Durvalumab |
title | Minimal Change Disease Associated With Durvalumab |
title_full | Minimal Change Disease Associated With Durvalumab |
title_fullStr | Minimal Change Disease Associated With Durvalumab |
title_full_unstemmed | Minimal Change Disease Associated With Durvalumab |
title_short | Minimal Change Disease Associated With Durvalumab |
title_sort | minimal change disease associated with durvalumab |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484110/ https://www.ncbi.nlm.nih.gov/pubmed/34622115 http://dx.doi.org/10.1016/j.ekir.2021.08.021 |
work_keys_str_mv | AT todamasatarog minimalchangediseaseassociatedwithdurvalumab AT fujiikentaro minimalchangediseaseassociatedwithdurvalumab AT katoai minimalchangediseaseassociatedwithdurvalumab AT yoshifujiayumi minimalchangediseaseassociatedwithdurvalumab AT komatsumotoaki minimalchangediseaseassociatedwithdurvalumab AT aminoyoshiaki minimalchangediseaseassociatedwithdurvalumab AT kitazonosatoru minimalchangediseaseassociatedwithdurvalumab AT hashiguchiakinori minimalchangediseaseassociatedwithdurvalumab AT ryuzakimunekazu minimalchangediseaseassociatedwithdurvalumab |